Advertisement
Advertisement

ADVM

ADVM logo

Adverum Biotechnologies Inc

4.84
USD
-0.39
-7.46%
Dec 18, 15:59 UTC -5
Closed
...

Adverum Biotechnologies Inc Profile

About

Adverum is a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases. Adverum develops gene therapy product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein. Adverum?s core capabilities include clinical development, novel vector discovery and in-house manufacturing expertise, specifically in scalable process development, assay development, and current Good Manufacturing Practices quality control.

Info & Links

CEO

Laurent Fischer

Headquarters

100 CARDINAL WAY
Redwood City, CA 94063, UNITED STATES

Industry

Pharmaceuticals Major

Sector

Health Technology

Website

http://www.adverum.com

Auditor

Ernst & Young LLP

Share holders

37

Employees

121

Adverum Biotechnologies Inc Statistics

Valuation Measures

Market Capitalization2

100.67M

Enterprise Value

7.82M

Enterprise Value/EBITDA(ttm)

-0.08

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.78

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

25.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

-678.35%

Return on Equity(ttm)

-65.14%

Return on Invested Capital(ttm)

-71.83%

Return on Assets(ttm)

-40.52%

Income Statement

Revenue(ttm)

1000.00K

Revenue Per Share(ttm)

0.05

Gross Profit(ttm)

1000.00K

EBITDA(ttm)3

-100.64M

Net Income Available to Common(ttm)

-94.11M

Diluted EPS(ttm)

-5.99

Share Statistics

Beta (5Y Monthly)

0.91

52-Week Change

-45.07%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

20.80M

Dividend Yield

0.00%

Float4

19.93M

% Held by Insiders

4.20%

% Held by Institutions

48.17%

Balance Sheet

Total Cash(mrq)

153.24M

Total Cash Per Share(mrq)

7.37

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

5.82%

Quick Ratio(mrq)

5.82%

Book Value Per Share(mrq)

6.93

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.08

Free Cash Flow(ytd)

-64.54M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement